Comparison of the prevalence of psychiatric co-morbidities in hepatitis C patients and hepatitis B patients in Saudi Arabia

Saudi Journal of Gastroenterology

Volumn 19, Issue 4, 2013, Pages 165-171

  Alhuthail, Yaser R ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Depression; general health questionnaire; hepatitis B; hepatitis C; psychiatric; Saudi Arabia; SF 36

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENERAL HEALTH QUESTIONNAIRE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; QUALITY OF LIFE; SAUDI ARABIA; SHORT FORM 36; SOCIAL INTERACTION; TINNITUS;

ADULT; COMORBIDITY; DEPRESSION; FEMALE; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SAUDI ARABIA;

EID: 84880990179     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.114514     Document Type: Article

References (48)

1. Available from: Http://www.who.int/csr/disease/hepatitis/ whocdscsrlyo2003/en/index4.html#incidence. [Last accessed on 2013 Mar 15].
2. Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors. Gen Hosp Psychiatry 2005;27:431-8
3. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156:271-8
4. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999 27;107:2S-9
5. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am J Psychiatry 2000;157:867-76
6. Pol S, Vallet-Pichard A, Corouge M, Mallet VO. Hepatitis C: Epidemiology, diagnosis, natural history and therapy. Contrib Nephrol 2012;176:1-9
7. Rall CJ, Dienstag JL. Epidemiology of hepatitis C virus infection. Semin Gastrointest Dis 1995;6:3-12
8. Madani TA. Hepatitis C virus infections reported over 11 years of surveillance in saudi arabia. Trans R Soc Trop Med Hyg 2009;103:132-6
9. Daw MA, Dau AA. Hepatitis C virus in Arab world: A state of concern. Scientific World Journal 2012;2012:719494
10. Abdel-Moneim AS, Bamaga MS, Shehab GM, Abu-Elsaad AA, Farahat FM. HCV infection among saudi population: High prevalence of genotype 4 and increased viral clearance rate. PLoS One 2012;7:e29781
11. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol 2012;4:74-80
12. Global Immunization Data. Available from: Http://www.who. int/immunization-monitoring/data/data-regions/en/index.html. [Last accessed on 2009 Oct 10].
13. Al-Faleh FZ, Ayoola EA, Al-Jeffry M, Arif M, Al-Rashed RS, Ramia S. Integration of hepatitis B vaccine into the expanded program on immunization: The Saudi Arabian experience. Ann Saudi Med 1993;13:231-6
14. Yovtcheva SP, Rifai MA, Moles JK, Van der Linden BJ. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001;42:411-5
15. Kraus MR, Schäfer A, Csef H, Scheurlen M, Faller H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000;41:377-84
16. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 2000;49:311-7
17. Carta MG, Hardoy MC, Garofalo A, Pisano E, Nonnoi V, Intilla G, et al. Association of chronic hepatitis C with major depressive disorders: Irrespective of interferon-alpha therapy. Clin Pract Epidemiol Ment Health 2007;3:22
18. Amodio P, Salari L, Montagnese S, Schiff S, Neri D, Bianco T, et al. Hepatitis C virus infection and health-related quality of life. World J Gastroenterol 2012;18:2295-9
19. Al-Huthail YR. Neuropsychiatric side-effects of interferon alfa therapy for hepatitis C and their management: A review. Saudi J Gastroenterol 2006;12:59-67
20. Alhamad A, Al-Faris EA. The validation of the general health questionnaire (ghq-28) in a primary care setting in saudi arabia. J Family Community Med 1998;5:13-9
21. Sabbah I, Drouby N, Sabbah S, Retel-Rude N, Mercier M. Quality of life in rural and urban populations in Lebanon using SF-36 health survey. Health Qual Life Outcomes 2003;1:30
22. Antonopoulou MD, Alegakis AK, Hadjipavlou AG, Lionis CD. Studying the association between musculoskeletal disorders, quality of life and mental health. A primary care pilot study in rural Crete, Greece. BMC Musculoskelet Disord 2009;10:143
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
24. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998;51:903-12
25. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute; 1993
26. Ware JE. The status of health assessment 1994. Ann Rev Public Health 1995;16:327-54
27. Stewart AL, Ware JE. Measuring functioning and well-being: The medical outcomes study approach. Durham, NC: Duke University Press; 1992
28. Manocchia M, Bayliss MS, Connor J, Keller SD, Shiely JC, Tasai C et al. SF-36 health survey annotated bibliography, 2nd ed. Boston, MA: The health assessment lab, New England Medical Center; 1998, 1988-1996
29. Beusterien KM, Steinwald B, Ware JE Jr. Usefulness of the SF-36 Health survey in measuring health outcomes in the depressed elderly. J Geriatr Psychiatry Neurol 1996;9:13-21
30. Wells KB, Burnam MA, Rogers W, Hays R, Camp P. The course of depression in adult outpatients. Results from the medical outcomes study. Arch Gen Psychiatry 1992;49:788-94
31. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, et al. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987;147:1577-80
32. Dieperink E, Ho SB, Tetrick L, Thuras P, Dua K, Willenbring ML. Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C. Gen Hosp Psychiatry 2004;26:237-40
33. Ho SB, Nguyen H, Tetrick LL, Opitz GA, Basara ML, Dieperink E. Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population. Am J Gastroenterol 2001;96:157-64
34. Pariante CM, Landau S, Carpiniello B, Cagliari Group. Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis. N Engl J Med 2002;347:148-9
35. Raison CL, Broadwell SD, Borisov AS, Manatunga AK, Capuron L, Woolwine BJ, et al. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun 2005;19:23-7
36. Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, et al. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 2011;52:127-32
37. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27:209-12
38. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999;30:1299-301
39. Johnson ME, Fisher DG, Fenaughty A, Theno SA. Hepatitis C virus and depression in drug users. Am J Gastroenterol 1998;93:785-9
40. Wilkinson J, Radkowski M, Eschbacher JM, Laskus T. Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 2010;59:1394-400
41. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004;78:5170-83
42. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002;76:10064-8
43. Cozzi A, Zignego AL, Carpendo R, Biagiotti T, Aldinucci A, Monti M, et al. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepat 2006;13:402-8
44. Schlaak JF, Trippler M, Hoyo-Becerra C, Erim Y, Kis B, Wang B, et al. Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy. PLoS One 2012;7:e38668
45. Ozkan M, Corapçioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, et al. Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med 2006;36:283-97
46. Atesci FC, Cetin BC, Oguzhanoglu NK, Karadag F, Turgut H. Psychiatric disorders and functioning in hepatitis B virus carriers. Psychosomatics 2005;46:142-7
47. Altindag A, Cadirci D, Sirmatel F. Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh) 2009;14:56-9
48. Patterson AL, Morasco BJ, Fuller BE, Indest DW, Loftis JM, Hauser P. Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: Do somatic symptoms compromise validity? Gen Hosp Psychiatry 2011;33:354-62